13 employees
Haima Therapeutics is a pre-clinical stage biotechnology company.
2016
$300K
from 2 investors over 2 rounds
Haima Therapeutics raised $300K on June 15, 2019
Investors: National Institutes of Health
Haima Therapeutics raised $150K on October 19, 2018
Investors: united-states-department-of-defense